679 related articles for article (PubMed ID: 17531123)
1. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
Zeng YB; Qian YS; Ma L; Gu HN
Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans.
Lee RE; Liu TT; Barker KS; Lee RE; Rogers PD
J Antimicrob Chemother; 2005 May; 55(5):655-62. PubMed ID: 15814599
[TBL] [Abstract][Full Text] [Related]
3. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter.
Karnani N; Gaur NA; Jha S; Puri N; Krishnamurthy S; Goswami SK; Mukhopadhyay G; Prasad R
Yeast; 2004 Feb; 21(3):219-39. PubMed ID: 14968428
[TBL] [Abstract][Full Text] [Related]
4. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
[TBL] [Abstract][Full Text] [Related]
5. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP
FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060
[TBL] [Abstract][Full Text] [Related]
6. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional profiles of response to terbinafine in Trichophyton rubrum.
Zhang W; Yu L; Yang J; Wang L; Peng J; Jin Q
Appl Microbiol Biotechnol; 2009 Apr; 82(6):1123-30. PubMed ID: 19234875
[TBL] [Abstract][Full Text] [Related]
8. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
[TBL] [Abstract][Full Text] [Related]
9. Serum repressing efflux pump CDR1 in Candida albicans.
Yang YL; Lin YH; Tsao MY; Chen CG; Shih HI; Fan JC; Wang JS; Lo HJ
BMC Mol Biol; 2006 Jul; 7():22. PubMed ID: 16839415
[TBL] [Abstract][Full Text] [Related]
10. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
[TBL] [Abstract][Full Text] [Related]
11. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
12. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
Navarro-Martínez MD; García-Cánovas F; Rodríguez-López JN
J Antimicrob Chemother; 2006 Jun; 57(6):1083-92. PubMed ID: 16585130
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Candida albicans growth by brominated furanones.
Duo M; Zhang M; Luk YY; Ren D
Appl Microbiol Biotechnol; 2010 Feb; 85(5):1551-63. PubMed ID: 19756586
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance in yeast Candida.
Prasad R; Kapoor K
Int Rev Cytol; 2005; 242():215-48. PubMed ID: 15598470
[TBL] [Abstract][Full Text] [Related]
15. Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs.
Larsen B; Anderson S; Brockman A; Essmann M; Schmidt M
Yeast; 2006 Aug; 23(11):795-802. PubMed ID: 16921553
[TBL] [Abstract][Full Text] [Related]
16. Application of deoxyribonucleic acid microarray analysis to the study of azole antifungal resistance in Candida albicans.
Barker KS; Rogers PD
Methods Mol Med; 2005; 118():45-56. PubMed ID: 15888934
[TBL] [Abstract][Full Text] [Related]
17. RTA2, a novel gene involved in azole resistance in Candida albicans.
Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
[TBL] [Abstract][Full Text] [Related]
18. Use of DNA microarray technology and gene expression profiles to investigate the pathogenesis, cell biology, antifungal susceptibility and diagnosis of Candida albicans.
Garaizar J; Brena S; Bikandi J; Rementeria A; Pontón J
FEMS Yeast Res; 2006 Nov; 6(7):987-98. PubMed ID: 17042748
[TBL] [Abstract][Full Text] [Related]
19. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
[TBL] [Abstract][Full Text] [Related]
20. Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against Candida albicans.
Khodavandi A; Alizadeh F; Vanda NA; Karimi G; Chong PP
Pharm Biol; 2014 Dec; 52(12):1505-9. PubMed ID: 24863276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
